Niamh M. O'boyle

152-160 Pearse Street, Dublin 2
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393.

RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 17, 2026

Analysis of FDA approvals, delays and denials of new drug applications, 2013-2023.

Analysis of FDA approvals, delays and denials of new drug applications, 2013-2023.

Journal: Drug discovery today

Published: May 15, 2026

Absorption and Effects of Patch Test Preparations of Hydroperoxides of Limonene and Hydroperoxides of Linalool in Human Ex Vivo Skin.

Absorption and Effects of Patch Test Preparations of Hydroperoxides of Limonene and Hydroperoxides of Linalool in Human Ex Vivo Skin.

Journal: Contact dermatitis

Published: January 06, 2026

Repeated Exposure to Hydroperoxides of Linalool Induces Immunologically Verified Allergic Contact Dermatitis.

Repeated Exposure to Hydroperoxides of Linalool Induces Immunologically Verified Allergic Contact Dermatitis.

Journal: Contact dermatitis

Published: August 29, 2025

Correction: Wang et al. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000.

Correction: Wang et al. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 29, 2025

Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119.

Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 29, 2025

Analysis of the structural diversity of heterocycles amongst European medicines agency approved pharmaceuticals (2014-2023).

Analysis of the structural diversity of heterocycles amongst European medicines agency approved pharmaceuticals (2014-2023).

Journal: RSC medicinal chemistry

Published: May 08, 2025

Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell lines.

Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell lines.

Journal: European journal of medicinal chemistry

Published: February 25, 2025

Terpene Hydroperoxides as Lipid Peroxidation Inducers: Biomimetic and HaCaT Cell Studies in Allergic Contact Dermatitis.

Terpene Hydroperoxides as Lipid Peroxidation Inducers: Biomimetic and HaCaT Cell Studies in Allergic Contact Dermatitis.

Journal: Contact dermatitis

Published: February 19, 2025

Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging.

Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging.

Journal: The British journal of dermatology

Published: February 13, 2025

Shaping Future Medicinal Chemists: Perspectives from European Schools of Pharmacy within the GP2A Network.

Shaping Future Medicinal Chemists: Perspectives from European Schools of Pharmacy within the GP2A Network.

Journal: Journal of medicinal chemistry

Published: January 28, 2025

(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer.

(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 24, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026